RhumbLine Advisers’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $686K | Buy |
118,896
+13,690
| +13% | +$79K | ﹤0.01% | 2461 |
|
2025
Q1 | $694K | Buy |
105,206
+5,215
| +5% | +$34.4K | ﹤0.01% | 2354 |
|
2024
Q4 | $871K | Buy |
99,991
+1,923
| +2% | +$16.7K | ﹤0.01% | 2318 |
|
2024
Q3 | $1.92M | Sell |
98,068
-6,108
| -6% | -$119K | ﹤0.01% | 1937 |
|
2024
Q2 | $2.14M | Sell |
104,176
-9,432
| -8% | -$194K | ﹤0.01% | 1849 |
|
2024
Q1 | $2.42M | Buy |
113,608
+1,545
| +1% | +$33K | ﹤0.01% | 1811 |
|
2023
Q4 | $1.61M | Buy |
112,063
+1,187
| +1% | +$17.1K | ﹤0.01% | 2016 |
|
2023
Q3 | $1.01M | Buy |
110,876
+5,260
| +5% | +$48K | ﹤0.01% | 2205 |
|
2023
Q2 | $1.12M | Buy |
105,616
+1,613
| +2% | +$17.1K | ﹤0.01% | 2228 |
|
2023
Q1 | $1.27M | Buy |
104,003
+3,300
| +3% | +$40.4K | ﹤0.01% | 2021 |
|
2022
Q4 | $1.25M | Buy |
100,703
+2,379
| +2% | +$29.5K | ﹤0.01% | 2024 |
|
2022
Q3 | $1.34M | Buy |
98,324
+6,733
| +7% | +$92K | ﹤0.01% | 1985 |
|
2022
Q2 | $1.68M | Buy |
91,591
+8,106
| +10% | +$149K | ﹤0.01% | 1856 |
|
2022
Q1 | $1.34M | Sell |
83,485
-7,131
| -8% | -$115K | ﹤0.01% | 2006 |
|
2021
Q4 | $1.27M | Sell |
90,616
-1,124
| -1% | -$15.7K | ﹤0.01% | 2112 |
|
2021
Q3 | $1.72M | Buy |
91,740
+2,900
| +3% | +$54.3K | ﹤0.01% | 1990 |
|
2021
Q2 | $1.85M | Buy |
88,840
+21,248
| +31% | +$443K | ﹤0.01% | 1988 |
|
2021
Q1 | $1.91M | Sell |
67,592
-2,498
| -4% | -$70.6K | ﹤0.01% | 1943 |
|
2020
Q4 | $2.29M | Buy |
70,090
+7,091
| +11% | +$232K | ﹤0.01% | 1791 |
|
2020
Q3 | $1.93M | Sell |
62,999
-8,360
| -12% | -$256K | ﹤0.01% | 1700 |
|
2020
Q2 | $1.16M | Buy |
71,359
+28,878
| +68% | +$471K | ﹤0.01% | 1983 |
|
2020
Q1 | $423K | Buy |
42,481
+281
| +0.7% | +$2.8K | ﹤0.01% | 2244 |
|
2019
Q4 | $580K | Buy |
42,200
+1,739
| +4% | +$23.9K | ﹤0.01% | 2297 |
|
2019
Q3 | $614K | Buy |
40,461
+2,649
| +7% | +$40.2K | ﹤0.01% | 2249 |
|
2019
Q2 | $745K | Buy |
37,812
+1,503
| +4% | +$29.6K | ﹤0.01% | 2193 |
|
2019
Q1 | $602K | Sell |
36,309
-809
| -2% | -$13.4K | ﹤0.01% | 2248 |
|
2018
Q4 | $521K | Buy |
37,118
+13,781
| +59% | +$193K | ﹤0.01% | 2282 |
|
2018
Q3 | $408K | Sell |
23,337
-310
| -1% | -$5.42K | ﹤0.01% | 2362 |
|
2018
Q2 | $430K | Buy |
23,647
+5,552
| +31% | +$101K | ﹤0.01% | 2367 |
|
2018
Q1 | $339K | Buy |
18,095
+4,160
| +30% | +$77.9K | ﹤0.01% | 2377 |
|
2017
Q4 | $213K | Sell |
13,935
-910
| -6% | -$13.9K | ﹤0.01% | 2596 |
|
2017
Q3 | $222K | Buy |
14,845
+746
| +5% | +$11.2K | ﹤0.01% | 2680 |
|
2017
Q2 | $131K | Buy |
+14,099
| New | +$131K | ﹤0.01% | 2864 |
|